250 related articles for article (PubMed ID: 10608150)
1. [Total body irradiation in hematology: clinical indications and prospects].
Corvò R
Recenti Prog Med; 1999 Nov; 90(11):601-4. PubMed ID: 10608150
[No Abstract] [Full Text] [Related]
2. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.
Kröger N; Zabelina T; Krüger W; Renges H; Stute N; Kabisch H; Jaburg N; Löliger C; Krüll A; Zander AR
Bone Marrow Transplant; 2001 Feb; 27(4):349-54. PubMed ID: 11313663
[TBL] [Abstract][Full Text] [Related]
3. Autotransplantation for chronic myeloid leukemia: is it useful?
Olavarria E
Haematologica; 2002 Jan; 87(1):3-6. PubMed ID: 11801458
[No Abstract] [Full Text] [Related]
4. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
[TBL] [Abstract][Full Text] [Related]
5. [Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
Schmid C; Weisser M; Ledderose G; Stötzer O; Schleuning M; Kolb HJ
Dtsch Med Wochenschr; 2002 Oct; 127(42):2186-92. PubMed ID: 12397547
[TBL] [Abstract][Full Text] [Related]
6. Influence of various conditioning regimens on the outcome of bone marrow transplantation for leukemia.
Devergie A; Socie G; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
Nouv Rev Fr Hematol (1978); 1991; 33(6):437-9. PubMed ID: 1818295
[TBL] [Abstract][Full Text] [Related]
7. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
Takami A; Chuhjo T; Nakao S
Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
[No Abstract] [Full Text] [Related]
8. Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Klingemann HG; Shepherd JD; Reece DE; Barnett MJ; Nantel SH; Sutherland HJ; Spinelli JJ; Phillips GL
Bone Marrow Transplant; 1994; 14 Suppl 4():S14-8. PubMed ID: 7728119
[No Abstract] [Full Text] [Related]
9. [Whole body irradiation in the conditioning of bone marrow transplantation. Current indications and limiting factors].
Ganem G; Cosset JM; Le Bourgeois JP
Ann Med Interne (Paris); 1989; 140(5):387-92. PubMed ID: 2688510
[No Abstract] [Full Text] [Related]
10. Allogeneic bone marrow transplantation from HLA-identical siblings following conditioning with busulphan and cyclophosphamide.
Wiktor-Jedrzejczak W; Szczylik C; Matej H; Pojda Z; Ratajczak MZ; Myc A; Siekierzyński M; Kansy J; Kłos M; Rybicki Z
Arch Immunol Ther Exp (Warsz); 1991; 39(4):441-7. PubMed ID: 1821620
[No Abstract] [Full Text] [Related]
11. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Herzig RH; Coccia PF; Strandjord SE; Warkintin PI; Cheung NK; Gordon EM; Novak L; Shina D
Semin Oncol; 1987 Jun; 14(2 Suppl 1):139-40. PubMed ID: 3296203
[No Abstract] [Full Text] [Related]
12. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Herzig RH; Coccia PF; Lazarus HM; Strandjord SE; Graham-Pole J; Cheung NK; Gordon EM; Gross S; Spitzer TR; Warkentin PI
Semin Oncol; 1985 Jun; 12(2 Suppl 3):184-6. PubMed ID: 3892700
[No Abstract] [Full Text] [Related]
13. Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission.
Snyder DS; Findley DO; Forman SJ; Nademanee AP; O'Donnell MR; Schmidt GM; Bierman PJ; Fahey JL; Krance RA; Sniecinski IJ
Blut; 1988 Jul; 57(1):7-13. PubMed ID: 3291991
[TBL] [Abstract][Full Text] [Related]
14. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks.
Igaki H; Karasawa K; Sakamaki H; Saito H; Nakagawa K; Ohtomo K; Tanaka Y
Strahlenther Onkol; 2005 Nov; 181(11):704-8. PubMed ID: 16254705
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation.
Copelan EA; Penza SL; Elder PJ; Ezzone SA; Scholl MD; Bechtel TP; Belt PS; Avalos BR
Bone Marrow Transplant; 2000 Jun; 25(12):1219-22. PubMed ID: 10871724
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic bone marrow transplantation for plasma cell leukemia following melphalan, cyclophosphamide and total body irradiation.
De Bock R; Nobels F; Schoemaker I; Van der Planken M; Peetermans M
Bone Marrow Transplant; 1989 May; 4(3):331. PubMed ID: 2659119
[No Abstract] [Full Text] [Related]
17. Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
Röttinger EM; Bartkowiak D; Bunjes D; Wennauer R; Dohr D
Strahlenther Onkol; 2003 Oct; 179(10):702-7. PubMed ID: 14566479
[TBL] [Abstract][Full Text] [Related]
18. [Autologous bone marrow transplantation].
Körbling M; Hunstein W; Fliedner TM
Dtsch Med Wochenschr; 1984 Feb; 109(7):265-71. PubMed ID: 6141929
[No Abstract] [Full Text] [Related]
19. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
[TBL] [Abstract][Full Text] [Related]
20. [Total therapeutic gamma irradiation in treating human hemoblastoses].
Shishkova TV; Danilova NB; Khrushchev VG; Grammatikati VS
Med Radiol (Mosk); 1982 Nov; 27(11):72-9. PubMed ID: 6757633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
